Hemodynamics #5 Flashcards

1
Q

Phosphodiesterase Inhibitors action / indication

A

Second line drug not used often. (For beta receptor down regulation)

  • Beta Receptor stimulation causes ATP to be converted to cyclic AMP
  • CAMP makes everything happen with cell.
  • cAMP broken down w/ phosphodiesterase
  • beta downregulation due to continuous beta receptor stimulation.
  • beta drugs are DC, phosphodiesterase inhibitors initiated.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Beta downregulation & steroid administration

A

Steroids tell RNA in cells to go into overdrive and create proteins which are used to create beta receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardiogenic shock vasopressin considerations

A

Pump failure - vasopressor stick a cork in the aorta.

-dopamine & Levophed May bridge temporarily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiogenic shock treatment

A
  • Adding volume helps to a point then hurts,
  • dopamine until dobutamine works
  • dobutamine assists w/ decreasing afterload
  • sodium Nitroprusside (nitropress) for vasodilation once BP maintained w/ dobutamine (let ventricles clear & prevent cardiomyopathies)
  • IABP & LVAD therapy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
Normal Pressures: 
CVP
CI
PA
PCWP
SVR
A
CVP: 2-6
CI: 2.5-4.2
PA: 15-25(PAS) / 8-15 (PAD)
PCWP: 4-12
SVR: 800-1200
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CVP Waveform

A
Preload for R side of heart
-hydration 1st, then RV function
Waveform: Sloppy cursive M
-A, C, V wave
-CVP range: mean average of waves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Low CVP

A
  1. Hypovolemia
  2. Vasodilation / decrease preload
  3. Negative pressure ventilation
    - spontaneous ventilation
    - hyperventilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

High CVP

A
  1. Hypervolemia
  2. Obstruction upstream
    - RV failure or RVI
    - cardiac Tampanade
    - positive pressure ventilation (always drops preload)
    - pulmonary hypertension
    - tight lungs
    - PE
    - pulmonic valve stenosis
    - tricuspid stenosis / regurgitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
IJ Depth of Insertion (cm)
CVP/ RA
RVP
PAP
PCWP
A
IJ (10's) - Subclavian (+5) - Femoral (+20)
CVP/ RA: 20
RVP: 30
PAP: 40
PCWP: 50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Subclavian Depth of Insertion (cm)

A
IJ (10's) - Subclavian (+5) - Femoral (+20)
CVP/ RA: 25
RVP: 35
PAP: 45
PCWP: 55
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Femoral Depth if Insertion (cm)

A
IJ (10's) - Subclavian (+5) - Femoral (+20)
CVP/ RA: 40
RVP: 50
PAP: 60
PCWP: 70
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Positive pressure ventilation benefits and complication

A

Right heart friendly during failure (gives Chambers ability to clear)

Not left heart friendly during failure (need to improve preload on left side)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RVP

A

-Not typically monitored
-can irritate ventricle causing VF/VT
-looks similar to VT
-Sharp upstroke and down stroke
-notching on ascending side indicates atrial kick
-Anachrotic Notch
-norm: systolic: 15-25, diastolic:0-5
(Diastolic Must be lower than CVP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pressures: Single vs fractional numbers

A

Single: mean numbers (preloads)

2 numbers: arterial (after loads)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PA waveform

A

R heart output, L heart preload

  • Pulmonary compliance
  • PAS: same as RVP
  • PAD: higher than RVDP (pulmonic valve closes and hold pressure for backflow into RV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Low PAP

A
  • Dehydration
  • RV failure or RVI (upstream blockage)
  • pulmonary stenosis (upstream blockage)
17
Q

High PAP

A

Blockage downstream

  • fluid overload
  • mitral stenosis or regurgitation
  • left ventricular failure
  • aortic stenosis/regurgitation
  • high pulmonary vascular resistance / HTN (hypoxia)
  • AV Communication (hole between AV chambers)
  • PE, ARDS, HPVR
18
Q

PA Placement

A
  • head up R Tilt position
  • Cath balloon down via jugular, subclavian, femoral into vena cava.
  • balloon inflated upon CVP waveform.
  • RVP waveform: balloon sails toward RV septum toward PA
  • PA waveform (same systolic, higher diastolic than RVP) balloon is deflated.
19
Q

PCWP Waveform

A
  • balloon inflated (1.5 ml) wedges in R lung
  • occluded blood from R heart, eliminating R heart pressures.
  • Low amplitude rolling waveform (similar to CVP, looks like fine VF)
  • diastole, mitral open. LVEDP
20
Q

High PCWP

A
  • Obstruction downstream
  • left ventricular failure
  • high SVR
  • constrictive pericarditis
  • mitral stenosis and regurgitation
  • fluid overload
  • pulmonary hypertension
  • hypoxia
  • ARDS
  • aortic stenosis
21
Q

Low PCWP

A
  • Obstruction upstream
  • RV failure
  • dehydration
  • vasodilation
22
Q

Inadvertent wedge troubleshooting

A

Caused by migration or balloon inflation

  1. Confirm balloon is fully deflated
  2. Have patient cough forcefully or roll to side and back (increases intrathoracic pressure’s and can pop back in to PA)
  3. Withdraw catheter until waveform returns to PA waveform (pullback very slowly and carefully)
23
Q

Inadvertent RV waveform troubleshooting

A

Step 1: inflate balloon

  • pads tip of Cath
  • sail back into PA

Step 2: deflate balloon, drawback until CVP waveform obtained.

  • safest technique
  • confirm balloon deflated otherwise tricuspid damage will occur
24
Q

CHF Treatment (5)

A
  1. Decrease preload (nitro, MS, Lasix)
  2. Decrease afterload (Nitroprusside (Nipride), nesiritude (natrocor))
  3. Decrease rate (beta blocker: Carvedilol (coreg) only(alpha& beta properties))
  4. Inhibit RAA System (ace inhibitors (prils-analapril))
  5. Improve Contractility (dobutamine B1&2 2:vasodilation(after load reduction) & phosphodiesterase inhibitors)